Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy.
Alison Stopeck, Fengting Yan, Lajos Pusztai, Manali Bhave et al.
Citations
6 citations
Journal
Journal of Clinical Oncology
Topics
Cancer Genomics and Diagnostics
Field-Weighted Citation Impact (FWCI)
5.62
article
Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy.
Alison Stopeck, Fengting Yan, Lajos Pusztai, Manali Bhave, Minetta C. Liu, Peter Kabos, Evanthia T. Roussos Torres, Wajeeha Razaq, Marina N. Sharifi, Ekaterina Kalashnikova, Carly Bess Scalise, Sima Ehsani, Sagar Sardesai, Paula Klein, Michelle Marie Loch, Angel Rodriguez, Alexandra Dos Santos Zimmer, Ursa Brown Glaberman
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(16_suppl)
Institutions
University of Southern California (US), University of Wisconsin–Madison (US), University of Arizona (US), Emory University (US), Oregon Health & Science University (US), Yale Cancer Center (US), Swedish Medical Center (US), Natera (United States) (US), New Mexico Cancer Center (US), UNM Comprehensive Cancer Center, University of Oklahoma Health Sciences Center (US), University of Colorado Anschutz Medical Campus (US), The Ohio State University (US), Stony Brook University (US), Louisiana State University Health Sciences Center New Orleans (US), University of Colorado Denver (US), Icahn School of Medicine at Mount Sinai (US)